Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - spironolactone 100 mg - tablets - spironolactone - edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. essential hypertention. primary hyperaldostronism. hypokalemia.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - felodipine 10 mg - tablets extended release - felodipine - moderate to severe hypertension. angina pectoris.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - felodipine 2.5 mg - tablets extended release - felodipine - hypertension. angina pectoris.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - allantoin 2 %; aluminium acetotartrate 0.4 % - ointment - benzocaine - for the relief of pain and inflammation caused by hemorrhoids.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - mupirocin 2 % - ointment - mupirocin - acute primary bacterial skin infections susceptible to the drug e.g. impetigo and folliculitis.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - diflucortolone valerate 0.1 %; isoconazole nitrate 1 % - cream - diflucortolone - for the local treatment of inflammatory skin conditions accompanied by secondary fungal infections.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - terazosin as hydrochloride dihydrate 5 mg - tablets - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - etodolac 400 mg - tablets - etodolac - for the management of signs and symptoms of osteoarthritis and rehumatoid arthritis.

Israel - Arabic - Ministry of Health

teva pharmaceutical indust.ltd - alendronic acid as sodium 70 mg - tablets - alendronic acid - for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.